Related Experiment Videos
Differential effects of monoamine oxidase inhibitors
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Application of the theory of signal detectability to kinesthetic discrimination tasks.
Journal of motor behavior·2013
Nature of kinesthesis as measured through techniques derived from the theory of signal detectability.
Journal of motor behavior·2013
Evidence of heterosexual bridging among syphilis-positive men who have sex with men.
Sexually transmitted infections·2006
Serological response to syphilis treatment in HIV-positive and HIV-negative patients attending sexually transmitted diseases clinics.
Sexually transmitted infections·2006
High rates of syphilis among STI patients are contributing to the spread of HIV-1 in India.
Sexually transmitted infections·2006
Smoke composition and predicting relationships for international commercial cigarettes smoked with three machine-smoking conditions.
Regulatory toxicology and pharmacology : RTP·2005
Is heat acclimation able to increase whole-body sensitivity to insulin?
Research communications in chemical pathology and pharmacology·1994
Vasodilator effects of clonidine on the mesenteric arterial beds in normotensive and spontaneously hypertensive rats.
Research communications in chemical pathology and pharmacology·1994
Elevation of ceruloplasmin activity involved in changes of hepatic metal concentration in primary biliary cirrhosis.
Research communications in chemical pathology and pharmacology·1994
Copper cytotoxicity impairs DNA synthesis but not protein phosphorylation upon growth stimulation in LEC mutant rat.
Research communications in chemical pathology and pharmacology·1994
Enhanced sensitivity of mdx mice to intramuscular injection of compound 48/80.
Research communications in chemical pathology and pharmacology·1994
Inhibition of antigen-induced airway hyperresponsiveness in rats: effects of ozagrel (a thromboxane A2 synthase inhibitor) and of CV-3988 (a platelet activating factor antagonist).
Research communications in chemical pathology and pharmacology·1994